• Raanan Berger, Israel | Chairperson

    Raanan Berger, Israel | Chairperson

    Dr. Raanan Berger is director of the Institute of Oncology at the Sheba Medical Center, which is Israel’s national hospital and the largest medical center in the Middle East. 
    Read More..
  • Aliza Ackerstein, Israel | Organizing Committee

    Aliza Ackerstein, Israel | Organizing Committee

    Aliza has an extensive career that spans over 30 years in the field of Life Sciences and Clinical Oncology...
  • Robin Foà, Italy I Organizing Committee

    Robin Foà, Italy I Organizing Committee

    Robin Foà is Professor of Hematology and Head of Hematology at the “Sapienza” University of Rome, Italy.
  • Talia Golan, Israel | Organizing Committee

    Talia Golan, Israel | Organizing Committee

    Talia is a clinician-scientist dedicated to advancing pancreatic cancer research, seeking to understand the cancer’s biology, with especially relevance to BRCA-associated tumors.
    Read More..
  • Michele Milella, Italy | Organizing Committee

    Michele Milella, Italy | Organizing Committee

    Dr. Milella graduated in Medicine and Surgery in 1992 and specialized in Medical Oncology in 1996. He received postdoctoral training at the University of Texas, M. D. Anderson Cancer Center
    Read More..
  • Jens Siveke, Germany | Organizing Committee

    Jens Siveke, Germany | Organizing Committee

    Jens is a physician-scientist focusing on preclinical and clinical research in solid tumors. I am Director of the Division of Solid Tumor Translational Oncology 
  • Donald Berry, USA

    Donald Berry, USA

    Donald Berry is professor in the Department of Biostatistics of the University of Texas M.D. Anderson Cancer Center. He received his Ph.D. in statistics from Yale University and has held endowed faculty positions at Duke University and M.D. Anderson. 
  • Maria Craze, USA

    Maria Craze, USA

    Maria A Craze is the Headquarters Director of Global Data Operations at Merck & Company, Inc. She supports the Executive Director and leadership team, of this 530+ person organization, in managing the strategic and tactical priorities and projects throughout the organization in addition to directly supporting a US group of 30 data managers and management staff.  

  • Aaron Goldman, USA

    Aaron Goldman, USA

    Aaron Goldman, PhD is heading research and development and immuno-oncology at Mitra Biotech, a personalized cancer medicine company headquartered in Boston MA, USA.
  • Jens Hoffmann, Germany

    Jens Hoffmann, Germany

    Dr. Hoffmann has special expertise for pharmacological investigations concerning endocrine tumors. Biomarker and translational research is another focus of his scientific work. He has published more than 50 original articles in peer reviewed journals and filed more than 30 patents.
  • Ivana Matic, Belgium

    Ivana Matic, Belgium

    Ivana is a certified MD who has spent past 10 years in clinical research, gaining experience in various country and regional job roles at MSD. She holds a position of Global Operations Lead – Agreements, as well as the process ownership over site ready support with an accent on the contracts, informed consents, budgets. Ivana has spent significant time on-site which helped her understand the full scope of the activities needed for a successful trial conductance.
  • Eibhlín Mulroe, Ireland

    Eibhlín Mulroe, Ireland

    Ms Mulroe was appointed CEO of the Cancer Trials Ireland (formerly ICORG) in June 2015 and manages a cross functional team of clinical program leads, Data & Statistics, Quality and Pharmacovigilance. 
  • Rachel Schor-Bardach, Israel

    Rachel Schor-Bardach, Israel

    Rachel Schor-Bardach is a board-certified radiologist at the Chaim Sheba Medical Center, in the Oncological Imaging and Cross-Sectional Imaging Section. She works daily in close collaboration with the medical oncologists of the various malignancies, in order to constantly improve patient care and outcome.
  • Wendy Selig, USA

    Wendy Selig, USA

    Wendy K.D. Selig is Founder and CEO of WSCollaborative, a firm that focuses on defining and implementing strategies for establishing winning cross-sector collaborations in the health care arena.  Selig’s clients include non-profit organizations, trade associations and leading pharmaceutical and biotech companies. She is known for her collaborative approach to engagement, with a record of “connecting the dots” and fostering novel partnerships. 
  • Marcia Sherry-Newby, USA

    Marcia Sherry-Newby, USA

    Marcia Sherry-Newby’s quality-related career began when she was in college with a summer quality management position at the Del Monte factory in Oakland, CA in 1986, and continued in the food industry until she entered the pharmaceutical industry in 1992 as a safety officer for Sanofi-Winthrop. 
  • Diane Simeone, USA

    Diane Simeone, USA

    Diane Simeone is the Laura and Isaac Perlmutter Professor of Surgery and Pathology at New York University and the Director of the Pancreatic Cancer Center at NYU Langone Health.  
  • Marco Vignetti, Italy

    Marco Vignetti, Italy

    Director, Central Office, GIMEMA Research Foundation, Rome, Italy
    University Doctor / Researcher, Hematology Dept., University Hospital “Umberto I”, “Sapienza” University, Rome, Italy
    Vice-President, Italian Association against Leukemia, Lymphoma and Myeloma –Rome, Italy
  • Clemens-Martin Wendtner, Germany

    Clemens-Martin Wendtner, Germany

    Professor Clemens-Martin Wendtner is Professor of Medicine and Director of the Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases, and Tropical Medicine at the Klinikum Schwabing, Munich, an academic hospital of the University of Munich.